Research Analysts at Liberum Capital Reiterate their “Buy” rating for Marwyn Value Investors (LON:MVI). The TP is GBX 159.00; Ballantyne Strong (BTN) Has 0.78 Sentiment

April 16, 2018 - By Michael Collier

They currently have a GBX 159.00 price target on Marwyn Value Investors (LON:MVI). Liberum Capital’s target would suggest a potential upside of 24.22% from the company’s last stock close price. This was disclosed in an analyst note on Monday, 16 April.

Ballantyne Strong Inc (BTN) investors sentiment increased to 0.78 in Q4 2017. It’s up 0.24, from 0.54 in 2017Q3. The ratio improved, as 7 hedge funds increased or opened new stock positions, while 9 decreased and sold their stakes in Ballantyne Strong Inc. The hedge funds in our database now hold: 6.38 million shares, up from 6.34 million shares in 2017Q3. Also, the number of hedge funds holding Ballantyne Strong Inc in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 5 Increased: 6 New Position: 1.

The stock increased 2.13% or $0.1 during the last trading session, reaching $4.8. About 7,868 shares traded. Ballantyne Strong, Inc (BTN) has declined 22.50% since April 16, 2017 and is downtrending. It has underperformed by 34.05% the S&P500.

Ballantyne Strong, Inc. designs, integrates, and installs technology solutions for the retail, financial, government, and cinema markets worldwide. The company has market cap of $69.23 million. It operates through two divisions, Cinema and Digital Media. It currently has negative earnings. The Cinema segment provides audio-visual products and accessories, such as digital projectors, projection screens, servers and library management systems, menu boards, flat panel displays, and sound systems.

Ballantyne Strong, Inc (NYSEAMERICAN:BTN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: